Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors-Reference-Cited by-同舟云学术

Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitors

Published:2021-08 Issue: Volume: Page:
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Gao Shenghua,Huang Tianguang^ORCID,Song Letian,Xu Shujing,Cheng Yusen,Cherukupalli Srinivasulu,Kang Dongwei,Zhao Tong,Sun Lin,Zhang Jian,Zhan Peng,Liu Xinyong^ORCID

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference128 articles.

1. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

2. SARS-CoV-2 is an appropriate name for the new coronavirus;Wu;Lancet,2020

3. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2;Nat Microbiol,2020

4. Coronavirus disease 2019 (COVID-19) situation report-51,2020

5. Coronavirus diversity, phylogeny and interspecies jumping;Woo;Exp Biol Med,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Fluorescent Naturally‐Occurring Inhibitor of SARS‐CoV‐2 Main Protease by AIE Fluorescent Probe;ChemMedChem;2024-09-12

2. New techniques and strategies in drug discovery (2020–2024 update);Chinese Chemical Letters;2024-09

3. Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review;Bioorganic Chemistry;2024-06

4. Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics;ACTA PHARM SIN B;2024

5. Development of an active-site titrant for SARS-CoV-2 main protease as an indispensable tool for evaluating enzyme kinetics;Acta Pharmaceutica Sinica B;2024-05